# United Therapeutics Corporation (UTHR): MoatMap facts

As of 17 Oct 2026. Research data, not investment advice.

As of 17 Oct 2026, MoatMap's StockRank for United Therapeutics Corporation (UTHR) is 93/100, ranked against 24,000+ stocks in 35 markets (Quality 87, Value 47, Momentum 61, each scored against its sector).

- StockRank: 93/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 87, Value 47, Momentum 61: each a 0-100 percentile within the stock's sector.
- Position: #1,978 overall, #219 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 541.51 USD on 15 Oct 2026.
- Insider filings, last 180 days: directors bought USD 864K; directors sold USD 694.8M.
- Buybacks, last 180 days: the company bought back USD 1.5B on 1 day.

Source: https://moatmap.ai/stock/UTHR
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker